Cryoablation to assist in kidney tumor surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of using renal cryoablation at the tumor site during partial nephrectomy, as an alternative to traditional methods that involve arterial ischemia to control bleeding. The focus is on patients with renal masses that are suitable for nephron-sparing surgery, particularly those with tumors larger than 2 cm. The study aims to determine if cryoablation can reduce blood loss and improve surgical outcomes without the need for blood flow interruption. The approach is particularly relevant in the context of robotic-assisted surgeries, which may lack cold ischemia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with ages between 45-90-year-old.
* Renal tumor ≤ 7 cm in the greatest extension, \>50% exophitic.

Exclusion Criteria:

* Prior renal surgery
* M1 Disease

Where it's running

• Urological Research Network
  Miami Lakes, Florida, United States Recruiting

Study contacts

• Principal investigator: Fernando J Bianco, MD — Urological research Network
• Study coordinator: Eusebio J Luna, MD
• Email: drluna@research.surgery
• Phone: 3058227227

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• Contrast-Enhanced Super-Resolution (CESR) Ultrasound for Imaging Breast, Liver, and Kidney Lesions

  The team will try a new contrast-enhanced super-resolution ultrasound (CESR) to see if it images known lesions in the breast, liver, or kidney more clearly in adults scheduled for biopsy and in healthy volunteers.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07225114

• Robot-assisted surgery for kidney tumors without sutures

  This study is testing a new robot-assisted surgery method for kidney tumors that doesn’t use stitches to see if it helps patients keep more of their kidney function compared to standard surgery.

  Recruiting RenJi Hospital · Shanghai · NCT06715878

• CD70-targeted immunoPET Imaging of Kidney Cancer

  This study is testing a new imaging technique that uses a special marker to help doctors see kidney cancer more clearly.

  Recruiting Phase 2 RenJi Hospital · Shanghai, Shanghai Municipality · NCT06680089

• Using vorolanib for treating advanced kidney cancer

  This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06676527

• Using a digital tool to improve kidney surgery planning

  This study is testing a new digital tool to see if it helps doctors plan kidney surgery better for patients with localized kidney cancer compared to just using regular CT scans.

  Recruiting at 5 sites University Hospital, Ghent · Aalst and 4 other locations · NCT06536439

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.